Category :

ZTO to Announce Fourth Quarter and Fiscal Year 2024 Financial Results on March 18, 2025 U.S. Eastern Time

SHANGHAI,Feb. 25,2025-- ZTO Express (Cayman) Inc. (NYSE: ZTO and SEHK: 2057) ("ZTO" or the "Company"),a leading and fast-growing express delivery company inChina,today announced th

Big DataFeb 26, 2025

"The Future of Travel": Trip.com Group to Showcase Next-Gen Tech at ITB Berlin 2025

Trip.com Group to launch joint Technology Game Changers: Future Trends in Travel & Tourism report at ITB Berlin Press Conference

ScienceFeb 26, 2025

ChipMOS REPORTS FOURTH QUARTER AND FULL YEAR 2024 RESULTS

6.3% Increase in Full Year 2024 Revenue Compared to Prior Year 13.0% Full Year 2024 Gross Margin Compared to 16.6% in 2023

Chip TechFeb 26, 2025

CNPC's Well Shendi Take-1 reaches 10,910-meter milestone

BEIJING,Feb. 25,2025-- A news report from chinadaily.com.cn: On February 20,China National Petroleum Corporation (CNPC) announced the successful completion of the Well Shendi Take-1,reaching an impres

SpaceFeb 26, 2025

ATRenew to Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025

SHANGHAI,Feb. 25,2025-- ATRenew Inc. ("ATRenew" or the "Company") (NYSE: RERE),a leading technology-driven pre-owned consumer electronics transactions and services platform in Chin

TechFeb 26, 2025

Guo Guangchang: Fosun Emphasizes Strategic Advancement and Exits, Focuses on Core Businesses, and Leverages Operational Capabilities to Participate in Global Markets

HONG KONG,Feb. 25,2025-- On 21 February,Guo Guangchang,Chairman of Fosun International spoke at the 25th Annual Conference of Yabuli China Entrepreneurs Forum 2025,stating that private enterprises are

BiologyFeb 26, 2025

YolTech Therapeutics Announces Positive Clinical Data for YOLT-203, an In Vivo Gene Editing Therapy for Primary Hyperoxaluria Type 1 (PH1)

SHANGHAI,Feb. 25,2025-- YolTech Therapeutics,a clinical-stage in vivo gene editing company committed to pioneering the next generation of precision genetic medicines,today reported positive results fr

BiologyFeb 26, 2025

CStone Announces Publication of GEMSTONE-303 Study Results for Sugemalimab (Cejemly®) in JAMA

Sugemalimab is the world\'s first anti-PD-L1 monoclonal antibody approved for the treatment of gastric or gastroesophageal junction (G/GEJ) adenocarcinoma. The GEMSTONE-303 study results support sugem

BiologyFeb 26, 2025

China committed to acting as an 'enabler'

BEIJING,Feb. 25,2025-- A report from People\'s Daily: Recently,a foreign scholar described China as an "enabler." This term vividly encapsulates China\'s commitment to building a community w

EnergyFeb 26, 2025

IIIF150 Unveils Latest Flagship Raptor 5G at MWC2025

BARCELONA,Spain,Feb. 25,2025-- IIIF150,the imaginative ultra-thin rugged phone manufacture,announced their new flagship Raptor 5G which will be showcased in Barcelona,and different tests onsite to cha

TechFeb 26, 2025
1 ... 220 221 222 223 224 225 226 ... 1295
Your premier source for cutting-edge news in the realms of technology, artificial intelligence, energy, and more. Explore the future of tech with Arinstar! Stay informed, stay inspired!

Quick Search

Explore our curated content, stay informed about groundbreaking innovations, and journey into the future of science and tech.

© ArinstarTechnology

Privacy Policy